insights_auto
Why is CSBR down 3,30%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
US$4,44
arrow_downward
-3,30%(-0,15) 1D
18 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4,55
High
US$4,60
Low
US$4,41
Mkt. cap
61,82 ລ້ານ
Avg. vol.
7,41 ພັນ
Volume
11,73 ພັນ
52-wk high
US$8,31
52-wk low
US$4,41
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Open
US$4,55
High
US$4,60
Low
US$4,41
Mkt. cap
61,82 ລ້ານ
Avg. vol.
7,41 ພັນ
Volume
11,73 ພັນ
52-wk high
US$8,31
52-wk low
US$4,41
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
The Motley Fool
·
54 ນາທີກ່ອນ
Stock Market Today, Nov. 18: S&P 500 Breaks Key Support as Fed Minutes Signal More Rate Hikes Ahead
Hedgeye
·
9 ຊົ່ວໂມງກ່ອນ
Why Negative Gamma Has Taken the Brakes Off the S&P 500
Barron's
·
3 ຊົ່ວໂມງກ່ອນ
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
US News Money
·
2 ຊົ່ວໂມງກ່ອນ
10 Best S&P 500 Stocks to Buy | Investing
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com